共 50 条
- [35] Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs [J]. Advances in Therapy, 2019, 36 : 817 - 827
- [38] Long-term outcomes in a Hispanic Population with Rheumatoid Arthritis Receiving Early Therapy with Disease-Modifying Anti-Rheumatic Drugs. [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 4015 - 4015
- [39] RHEUMATOID ARTHRITIS TREATMENT WITH COMBINATION OF THREE CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS) AND ITS EFFECTIVENESS ON DISEASE CONTROL IN A SHORT TERM COMPARED TO BIOLOGIC DMARDS TREATMENT AFTER PROPENSITY SCORE MATCHING PROCEDURE IMPLEMENTED [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 975 - 976
- [40] Elicitation of Rheumatologist Preferences for the Treatment of Patients with Rheumatoid Arthritis After the Failure of a First Conventional Synthetic Disease-Modifying Anti-Rheumatic Agent [J]. Rheumatology and Therapy, 2021, 8 : 921 - 935